TCT 33: Racial Disparities in the Utilization and Outcomes of LAA Occlusion using WATCHMAN FLX: A SURPASS analysis of the NCDR LAAO Registry

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation; Edwards Lifesciences